Main Business：Interventional products for cardiovascular, cerebrovascular, and structural heart diseasesCompany Type：Medical Device Supplier
Operating Model：Manufacturers
Establishment：2007
Established in 2007 by Dr. Jianhua Sun and headquartered in Tianjin, China, SINOMED stands as a leading specialist in the meticulous research, development, production, and distribution of state-of-the-art interventional medical devices. Operating from two flagship facilities within China, our Tianjin site is dedicated to combatting cardiovascular and structural heart diseases, while Neurovita, situated in Suzhou, focuses on advancing treatments for neurovascular strokes. With expansive facilities spanning a total of 30,000 m² and equipped with pristine 10,000 m² class 10,000 cleanrooms, SINOMED ensures the highest standards of cleanliness and technological sophistication. Additionally, our recent acquisition of a distinguished R&D company based in Fremont, California, USA, marks an exciting expansion of our capabilities. In 2019, SINOMED achieved another milestone by becoming a public company listed on the Shanghai SST Stock Exchange.
Throughout our illustrious 19-year journey, SINOMED has progressively broadened its global presence, strategically targeting pivotal markets across Asia, Europe, Latin America, Africa, the United States, and Japan.
At SINOMED, our mission is clear: to lead the global healthcare industry by delivering innovative medical devices that enhance patient well-being and support healthcare professionals in their essential work. Our core values of excellence, integrity, and collaboration serve as the guiding principles behind every aspect of our operations.
We are deeply committed to upholding the highest standards of quality across all facets of our business, from research and development to production and distribution. Through continuous innovation and investment in advanced technologies, we strive to provide medical solutions that positively impact lives worldwide.
Beyond achieving product excellence, we are dedicated to forging robust partnerships within the healthcare community. Our objective is to ensure that our devices are accessible to all, irrespective of geographical location or economic circumstance.
In essence, at SINOMED, we are not merely manufacturers of medical devices; we are pioneers of a new era of healthcare innovation, fueled by our unwavering passion for improving patient outcomes and contributing to the advancement of global health.